Atomized Inhalation ICG for Treatment of Congenital Lung Malformations

ConditionsPulmonary Sequestration Congenital Pulmonary Airway Malformation Indocyanine Green Thoracoscopic Surgery Children

Trial statusRecruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age3-14

SponsorJiexiong Feng

About this trial

To investigate the safety and effectiveness of preoperative aerosol inhalation ICG solution for thoracoscopic accurate resection of congenital lung malformations in children.

Eligibility criteria

Qualifiers

children with congenital lung malformations diagnosed by CT or MRI scan

Disqualifiers

1. ages <3 months and >14 years 2. complicated other life-threatening disease; 3. complicated severely pulmonary infection

Trial design

Treatments tested in this trial

atomized inhalation ICG before thoracoscope pneumonectomy

Treatment groups

50 Participants

are divided into 1 treatment group

Sponsors and collaborators

Jiexiong Feng

Lead sponsor

Tongji Hospital

Sponsor institution

Source ClinicalTrials.gov